HomeCompareTLIS vs YUM

TLIS vs YUM: Dividend Comparison 2026

TLIS yields 70.42% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLIS wins by $964.3K in total portfolio value
10 years
TLIS
TLIS
● Live price
70.42%
Share price
$2.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.07M
Annual income
$282,657.96
Full TLIS calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — TLIS vs YUM

📍 TLIS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLISYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLIS + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLIS pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLIS
Annual income on $10K today (after 15% tax)
$5,985.92/yr
After 10yr DRIP, annual income (after tax)
$240,259.27/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, TLIS beats the other by $205,882.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLIS + YUM for your $10,000?

TLIS: 50%YUM: 50%
100% YUM50/50100% TLIS
Portfolio after 10yr
$590.1K
Annual income
$161,550.74/yr
Blended yield
27.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

TLIS
Analyst Ratings
1
Hold
3
Sell
Consensus: Sell
Altman Z
-12.3
Piotroski
1/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLIS buys
0
YUM buys
0
No recent congressional trades found for TLIS or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLISYUM
Forward yield70.42%1.86%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$1.07M$107.9K
Annual income after 10y$282,657.96$40,443.52
Total dividends collected$914.3K$81.2K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusSellHold

Year-by-year: TLIS vs YUM ($10,000, DRIP)

YearTLIS PortfolioTLIS Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$17,742$7,042.25$10,982$282.06+$6.8KTLIS
2$30,661$11,677.14$12,189$438.29+$18.5KTLIS
3$51,667$18,859.73$13,731$688.32+$37.9KTLIS
4$84,985$29,701.39$15,789$1,097.12+$69.2KTLIS
5$136,593$45,658.47$18,679$1,785.08+$117.9KTLIS
6$214,738$68,583.71$22,975$2,988.18+$191.8KTLIS
7$330,537$100,766.97$29,784$5,200.49+$300.8KTLIS
8$498,633$144,958.95$41,408$9,539.16+$457.2KTLIS
9$737,910$204,372.63$63,071$18,765.27+$674.8KTLIS
10$1,072,222$282,657.96$107,930$40,443.52+$964.3KTLIS

TLIS vs YUM: Complete Analysis 2026

TLISStock

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Full TLIS Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this TLIS vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLIS vs SCHDTLIS vs JEPITLIS vs OTLIS vs KOTLIS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.